ABBVIE INC. vs. Rhythm Pharmaceuticals, Inc. Common Stock
ABBVIE INC. (ABBV) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| ABBV | RYTM | |
|---|---|---|
| Market Cap | $466.45 billion | $7.21 billion |
| Revenue (TTM) | $64.39 billion | $239.92 million |
| Net Income (TTM) | $6.32 billion | $-205,346,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | RYTM | |
|---|---|---|
| P/E Ratio | 74.56 | — |
| Price / Book | -79.22 | 70.01 |
| Price / Sales | 7.24 | 30.05 |
ABBV leads on 2 of 2 valuation factors.
Profitability
| ABBV | RYTM | |
|---|---|---|
| Net Margin | 9.81% | -85.59% |
| Return on Equity | -107.29% | -199.40% |
ABBV leads on 2 of 2 profitability factors.
Dividend
| ABBV | RYTM | |
|---|---|---|
| Dividend Yield | 2.62% | — |
| Payout Ratio | 195.48 | — |
ABBV and RYTM split the dividend factors evenly.
Risk & Sentiment
| ABBV | RYTM | |
|---|---|---|
| Short Interest | 0.85% | 1.12% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, RYTM overview, RYTM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.